Published in Biochemistry on November 24, 1981
Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci U S A (1983) 1.37
Cardiac angiotensin II type I and type II receptors are increased in rats submitted to experimental hypothyroidism. J Physiol (2007) 0.93
Molecular and Pathophysiological Features of Angiotensinogen: A Mini Review. N Am J Med Sci (Boston) (2011) 0.88
A new member of the plasma protease inhibitor gene family. Nucleic Acids Res (1986) 0.85
Angiotensinogen production by rat hepatoma cells in culture and analysis of its regulation by techniques of somatic cell genetics. J Cell Biol (1983) 0.83
Characterization of precursor and secreted forms of human angiotensinogen. J Clin Invest (1985) 0.80
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell (1986) 8.87
The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell (1985) 7.45
PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res (1992) 3.95
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet (1992) 3.33
Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem (1991) 3.22
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A (1988) 3.21
The number needed to treat: a clinically useful nomogram in its proper context. BMJ (1996) 2.89
Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. Proc Natl Acad Sci U S A (1985) 2.44
Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension (1994) 2.41
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet (2001) 2.28
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest (1996) 2.20
Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology (1972) 2.13
Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ (1988) 1.91
The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem (1991) 1.86
Complete amino acid sequence and maturation of the mouse submaxillary gland renin precursor. Nature (1982) 1.83
Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem (1991) 1.65
Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol (1997) 1.65
Do physicians estimate reliably the cardiovascular risk of hypertensive patients?. Medinfo (1995) 1.62
Immunocytochemical localization of angiotensinogen in rat liver and kidney. Cell Tissue Res (1983) 1.62
The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem (1995) 1.58
Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am J Physiol (1986) 1.55
Cardiac pheochromocytomas. Ann Thorac Surg (1992) 1.55
Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J Clin Endocrinol Metab (1997) 1.52
Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain. J Neurochem (2001) 1.51
Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem (1996) 1.49
The critical role of tissue angiotensin-converting enzyme as revealed by gene targeting in mice. J Clin Invest (1997) 1.48
Multiple forms of human renin. Purification and characterization. J Biol Chem (1979) 1.45
Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison. J Am Coll Cardiol (1990) 1.43
Blood pressure response to angiotensin II, low-density lipoprotein cholesterol and polymorphisms of the angiotensin II type 1 receptor gene in hypertensive sibling pairs. J Mol Med (Berl) (2001) 1.43
The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem (1992) 1.42
Association of hypertension with T594M mutation in beta subunit of epithelial sodium channels in black people resident in London. Lancet (1998) 1.42
Maturation-dependent changes of angiotensin receptor expression in fowl. Am J Physiol Regul Integr Comp Physiol (2003) 1.41
Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc Res (2005) 1.39
Renin secreting tumors: diagnosis, conservative surgical approach and long-term results. J Urol (1995) 1.39
Can echocardiography identify mildly hypertensive patients at high risk, left untreated based on current guidelines? J Hypertens (1999) 1.38
Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study. Hypertension (1994) 1.38
Identification of the rat adapter Grb14 as an inhibitor of insulin actions. J Biol Chem (1998) 1.38
Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J Biol Chem (1994) 1.35
Tumor recurrence and hypertension persistence after successful pheochromocytoma operation. Hypertension (1997) 1.31
Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension (1993) 1.29
Molecular cloning of genes encoding branched-chain keto acid dehydrogenase of Pseudomonas putida. J Bacteriol (1987) 1.28
Structure of human angiotensinogen gene. DNA (1989) 1.28
Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav (1993) 1.28
Benefits of a computer-assisted education program for hypertensive patients compared with standard education tools. Patient Educ Couns (1995) 1.27
Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A (1996) 1.26
Species distribution of testosterone-binding globulin. Biol Reprod (1973) 1.26
Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res (1988) 1.24
Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet (1997) 1.24
Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension (1994) 1.24
Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J Lab Clin Med (1991) 1.23
Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet (1997) 1.23
Mechanisms of receptor-mediated transmembrane communication. Cold Spring Harb Symp Quant Biol (1986) 1.22
Early expression of all the components of the renin-angiotensin-system in human development. Am J Pathol (1996) 1.22
The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral, non-duplicated form of the enzyme. FEBS Lett (1989) 1.22
Human chorionic cells in primary culture: a model for renin biosynthesis. J Clin Endocrinol Metab (1982) 1.22
Role of angiotensinogen in blood pressure homeostasis. Hypertension (1982) 1.21
A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin-angiotensin system. J Biol Chem (1995) 1.19
Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension (1996) 1.18
Mechanism of renin release following furosemide diuresis in rabbit. Am J Physiol (1968) 1.17
A novel rat carboxypeptidase, CPA2: characterization, molecular cloning, and evolutionary implications on substrate specificity in the carboxypeptidase gene family. J Biol Chem (1988) 1.17
Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol (2000) 1.16
Replacement of insulin receptor tyrosine residues 1162 and 1163 does not alter the mitogenic effect of the hormone. Proc Natl Acad Sci U S A (1988) 1.16
Angiotensinogen: an attractive and underrated participant in hypertension and inflammation. Hypertension (1991) 1.16
Use of a specific antiserum for renin detection in human kidney. J Histochem Cytochem (1980) 1.15
Molecular cloning of a mouse submaxillary gland renin cDNA fragment. Proc Natl Acad Sci U S A (1981) 1.15
Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J Biol Chem (1996) 1.15
The expression of thyrotropin receptor in the brain. Endocrinology (2001) 1.14
Expression of type 1 angiotensin II receptor subtypes and angiotensin II-induced calcium mobilization along the rat nephron. J Am Soc Nephrol (1997) 1.13
Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice. J Clin Invest (2000) 1.12
Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization. Histochemistry (1986) 1.12
Effects of induced hyperthyroidism on steroid metabolism in man. J Clin Endocrinol Metab (1971) 1.12
A membrane-anchored cytoplasmic domain of the human insulin receptor mediates a constitutively elevated insulin-independent uptake of 2-deoxyglucose. Mol Endocrinol (1987) 1.11
Cloning and expression pattern of EPAS1 in the chicken embryo. Colocalization with tyrosine hydroxylase. FEBS Lett (1999) 1.11
Cloning and expression of an evolutionary conserved single-domain angiotensin converting enzyme from Drosophila melanogaster. J Biol Chem (1995) 1.11
Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci U S A (1999) 1.11
Possible familial origin of multifocal renal artery fibromuscular dysplasia. J Hypertens (1997) 1.09
Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine. Br J Clin Pharmacol (1987) 1.09
Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol (1987) 1.08
Measurement of urinary kallikrein activity. Species differences in kinin production. Biochim Biophys Acta (1981) 1.08